Home › Long COVID › Ohio › Cincinnati
Long COVID clinical trials in Cincinnati, OH
4 studies for Long COVID are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
RecruitingPhase 3
- Hometown Urgent Care and Research, Cincinnati
- Velocity Clinical Research, Cincinnati
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati College of Medicine (UC Holmes), Cincinnati
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
About Long COVID
Anyone who has had COVID-19 can have long-lasting symptoms, know as long COVID. Learn about the symptoms and how to manage them, diagnosis, and prevention.
More about Long COVID on MedlinePlus
Long COVID trials in other cities
- New York City, NY17 studies
- Houston, TX14 studies
- Chicago, IL12 studies
- Washington, DC12 studies
- Boston, MA11 studies
- Baltimore, MD11 studies
- Hialeah, FL8 studies
- Durham, NC8 studies
- San Francisco, CA8 studies
- Atlanta, GA7 studies
- San Diego, CA7 studies
- Miami, FL7 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)26 studies
- Breast Cancer24 studies
- Heart Failure22 studies
- Metastatic Cancer21 studies
- Colorectal Cancer20 studies
- Obesity20 studies
- Acute Myeloid Leukemia20 studies
- Prostate Cancer19 studies
- Ovarian Cancer18 studies
- Lung Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.